Distinguishing neurofibroma from desmoplastic melanoma: The value of the cd34 fingerprint

Journal of Cutaneous Pathology

Volumn 38, Issue 8, 2011, Pages 625-630

  Yeh, Iwei ^a   McCalmont, Timothy H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD34; desmoplastic melanoma; fingerprint; neurofibroma; SOX 10

Indexed keywords

CD34 ANTIGEN; TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; HUMAN; MELANOMA; METABOLISM; NEUROFIBROMA; SKIN TUMOR;

ANTIGENS, CD34; CELL PROLIFERATION; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; NEUROFIBROMA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960565127     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01700.x     Document Type: Article

References (16)

1. Nonaka D, Chiriboga L, Rubin BP., Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol 2008; 32: 1291.
2. Ramos-Herberth FI, Karamchandani J, Kim J, Dadras SS., SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol 2010; 37: 944.
3. Kucher C, Zhang PJ, Pasha T, et al., Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol 2004; 26: 452.
4. Busam KJ, Iversen K, Coplan KC, Jungbluth AA., Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001; 25: 197.
5. Nonaka D, Chiriboga L, Rubin BP., Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors. J Cutan Pathol 2008; 35: 1014.
6. McCalmont TH, LeBoit PE., Polygonal CD34 positivity portends trichilemmal differentiation. J Cutan Pathol 2010; 37: 923, 924.
7. Tardío JC., CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol 2009; 36: 89.
8. Holyoake TL, Alcorn MJ., CD34+ positive haemopoietic cells: biology and clinical applications. Blood Rev 1994; 8: 113.
9. Poblet E, Jiménez F., CD10 and CD34 in fetal and adult human hair follicles: dynamic changes in their immunohistochemical expression during embryogenesis and hair cycling. Br J Dermatol 2008; 159: 646.
10. Narvaez D, Kanitakis J, Faure M, Claudy A., Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol 1996; 18: 283.
11. Smith K, Germain M, Williams J, Skelton H., CD34-positive cellular blue nevi. J Cutan Pathol 2001; 28: 145.
12. Khalifa MA, Montgomery EA, Ismiil N, Azumi N., What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein. Am J Clin Pathol 2000; 114: 123.
13. Weiss SW, Nickoloff BJ., CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993; 17: 1039.
14. Yeh I, McCalmont TH., Fingerprint CD34 immunopositivity. J Cutan Pathol 2010; 37: 1128.
15. Narvaez D, Kanitakis J, Faure M, Claudy A., Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol 1996; 18: 283.
16. Wessel C, Westhoff CC, Nowak K, Moll I, Barth PJ., CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin. Virchows Arch 2008; 453: 485.